| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |